These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5960176)

  • 1. Analogs of tetrahydrofolic acid. 33. Hydrophobic bonding to dihydrofolic reductase V. Inhibition by some pyrimidines bridged to benzoic acid.
    Baker BR; Ho BT; Coward JK; Santi DV
    J Pharm Sci; 1966 Mar; 55(3):302-8. PubMed ID: 5960176
    [No Abstract]   [Full Text] [Related]  

  • 2. Analogs of tetrahydrofolic acid 34. Hydrophobic bonding to dihydrofolic reductase VI. Mode of phenyl binding of some 6-arylpyrimidines.
    Baker BR; Shapiro HS
    J Pharm Sci; 1966 Mar; 55(3):308-17. PubMed ID: 5960177
    [No Abstract]   [Full Text] [Related]  

  • 3. Analogs of tetrahydrofolic acid. 32. Hydrophobic bonding to dihydrofolic reductase IV. Inhibition by p-substituted benzoic and benzoyl-L-glutamic acids.
    Baker BR; Schwan TJ; Novotny J; Ho BT
    J Pharm Sci; 1966 Mar; 55(3):295-302. PubMed ID: 5960175
    [No Abstract]   [Full Text] [Related]  

  • 4. Analogs of tetrahydrofolic acid. XXVII. Hydrophobic bonding to dihydrofolic reductase by 2-amino-4,6-disubstituted-5-alkylpyrimidines and 1-alkyl-4,6-diamino-1,2-dihydro-s-triazines.
    Baker BR; Beng-Thong Ho; Santi DV
    J Pharm Sci; 1965 Oct; 54(10):1415-24. PubMed ID: 5883214
    [No Abstract]   [Full Text] [Related]  

  • 5. Analogs of tetrahydrofolic acid XXV. 2,4-Diamino-6-phenethylpteridine, an inhibitor of dihydrofolic reductase.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Sep; 54(9):1261-5. PubMed ID: 5881216
    [No Abstract]   [Full Text] [Related]  

  • 6. Analogs of tetrahydrofolic acid XX. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol on inhibition of dihydrofolic reductase and thymidylate synthetase II.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Aug; 54(8):1187-90. PubMed ID: 5882225
    [No Abstract]   [Full Text] [Related]  

  • 7. Irreversible enzyme inhibitors. 88. Differential irreversible inhibition of dihydrofolic reductase from different species.
    Baker BR; Jordaan JH
    J Pharm Sci; 1967 May; 56(5):660-1. PubMed ID: 5340324
    [No Abstract]   [Full Text] [Related]  

  • 8. Analogs of tetrahydrofolic acid XXIV. Further observations on the mode of pyrimidyl binding to dihydrofolic reductase and thymidylate synthetase by the 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol type of inhibitor.
    Baker BR; Santi DV
    J Pharm Sci; 1965 Sep; 54(9):1252-7. PubMed ID: 5881214
    [No Abstract]   [Full Text] [Related]  

  • 9. Irreversible enzyme inhibitors. LXXI. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. V. Derivatives of 6-phenylpyrimidine.
    Baker BR; Shapiro HS
    J Pharm Sci; 1967 Jan; 56(1):33-8. PubMed ID: 6030490
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. LXXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VII. Derivatives of 2,4-diaminopyrimidine. I.
    Baker BR; Jackson GD; Meyer RB
    J Pharm Sci; 1967 May; 56(5):566-70. PubMed ID: 6040577
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. LXXXIV. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IX. Derivatives of 2,4-diaminopyrimidine. 3.
    Baker BR; Meyer RB
    J Pharm Sci; 1967 May; 56(5):570-6. PubMed ID: 6032766
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. LXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VI. Derivatives of hydrophobically bonded p-alkyl and p-aralkyl benzoic acids.
    Baker BR; Schwan TJ; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):38-42. PubMed ID: 6030491
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation of folic acid reductase from Streptococcus faecium (ATCC 8043).
    Speck EL; Affronti LF
    J Bacteriol; 1969 Mar; 97(3):1160-4. PubMed ID: 5776522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible enzyme inhibitors. LXXXVII. Hydrophobic bonding to dihydrofolic reductase. IX. Mode of binding of m-aryloxyalkyl groups on 4,6-diamino-1,2-dihdro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Lourens GJ
    J Pharm Sci; 1967 Jul; 56(7):871-5. PubMed ID: 6068108
    [No Abstract]   [Full Text] [Related]  

  • 15. Folate reductase from mouse liver. Purification, activation by metals and inhibition by some 6-(1-adamantyl) derivatives.
    Soucek J; Slavíková V; Kuchar M; Kotýnková E
    Biochem Pharmacol; 1972 Jul; 21(14):1907-19. PubMed ID: 4649341
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tetrahydrofolic-dependent enzymes and dihydrofolic reductase in normal and psoriasic human epidermis and in cutaneous epithelial neoplasms].
    Finzi AF; Martelli M; Tonato M; Colonna A; Grignani F
    Minerva Dermatol; 1965 Dec; 40(12):449-56. PubMed ID: 5218347
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. LXXXVI. Hydrophobic bonding to dihydrofolic reductase. 8. Substituted-1-aryl-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines.
    Baker BR; Ho BT; Lourens GJ
    J Pharm Sci; 1967 Jun; 56(6):737-42. PubMed ID: 5231391
    [No Abstract]   [Full Text] [Related]  

  • 18. Dihydrofolate reductase from guinea pig liver and small intestine.
    Bertino JR; Iannotti AT; Perkins JP; Johns DG
    Biochem Pharmacol; 1966 May; 15(5):563-71. PubMed ID: 5227348
    [No Abstract]   [Full Text] [Related]  

  • 19. Irreversible enzyme inhibitors. LXX. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IV. Substituted 1-phenyl-1,2-dihydro-s-triazines.
    Baker BR; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):28-32. PubMed ID: 6030489
    [No Abstract]   [Full Text] [Related]  

  • 20. Analogs of tetrahydrofolic acid XXII. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol thymidylate synthetase. 3.
    Baker BR; Coward JK
    J Pharm Sci; 1965 May; 54(5):714-9. PubMed ID: 5847011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.